Croda International Plc (LON:CRDA - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is GBX 3,230.
CRDA has been the subject of several analyst reports. Citigroup raised their price objective on Croda International from GBX 3,050 to GBX 3,200 and gave the company a "neutral" rating in a report on Wednesday. Jefferies Financial Group reissued a "hold" rating and set a GBX 3,000 price target on shares of Croda International in a research report on Wednesday, April 22nd. Finally, Berenberg Bank restated a "buy" rating and issued a GBX 3,600 price target on shares of Croda International in a research note on Wednesday.
View Our Latest Report on CRDA
Croda International Price Performance
Shares of CRDA stock opened at GBX 3,160 on Wednesday. The company has a current ratio of 1.99, a quick ratio of 2.25 and a debt-to-equity ratio of 31.85. Croda International has a 1 year low of GBX 2,426.77 and a 1 year high of GBX 3,312. The firm's fifty day moving average price is GBX 2,989.04 and its two-hundred day moving average price is GBX 2,900.62. The firm has a market capitalization of £4.40 billion, a P/E ratio of 71.17, a PEG ratio of 1.40 and a beta of 0.92.
Insider Activity at Croda International
In other news, insider Steve Foots sold 73 shares of the stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of GBX 2,840, for a total value of £2,073.20. Over the last three months, insiders purchased 25 shares of company stock valued at $72,490. Corporate insiders own 0.83% of the company's stock.
Croda International Company Profile
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.